These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9344196)

  • 1. Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia.
    Baer SC; Casaubon L; Younes M
    J Am Acad Dermatol; 1997 Oct; 37(4):575-7. PubMed ID: 9344196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study on keratin expression in certain cutaneous epithelial neoplasms. Basal cell carcinoma, pilomatricoma, and seborrheic keratosis.
    Shimizu N; Ito M; Tazawa T; Sato Y
    Am J Dermatopathol; 1989 Dec; 11(6):534-40. PubMed ID: 2481408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A; Smoller BR
    Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.
    Lavrijsen AP; Tieben LM; Ponec M; van der Schroeff JG; van Muijen GN
    Arch Dermatol Res; 1989; 281(2):83-8. PubMed ID: 2476080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis].
    Sutter C; Wersin R; Varnai M; Friemann J
    Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of low-molecular-weight stress protein HSP 27 in normal skin and common cutaneous lesions.
    Gandour-Edwards R; McClaren M; Isseroff RR
    Am J Dermatopathol; 1994 Oct; 16(5):504-9. PubMed ID: 7802164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in seborrheic keratoses.
    Clemmensen OJ; Sjølin KE
    Acta Derm Venereol; 1986; 66(2):158-61. PubMed ID: 2424241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.
    Rose CL; Chakravarti N; Curry JL; Torres-Cabala CA; Bassett R; Prieto VG; Tetzlaff MT
    J Cutan Pathol; 2012 Aug; 39(8):762-8. PubMed ID: 22764884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities.
    Ginarte M; García-Caballero T; Fernández-Redondo V; Beiras A; Toribio J
    J Cutan Pathol; 2000 Jul; 27(6):276-82. PubMed ID: 10885403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.